Naringenin: its chemistry and roles in neuroprotection

References

• Patel DK, Kumar R, Prasad SK, Hemalatha S. Pharmacologically screened aphrodisiac plant – a review of current scientific literature. Asian Pac J Trop Biomed. 2011a;1(1):S131–S138.
   Google Scholar
• Patel DK, Laloo D, Kumar R, Hemalatha S. Pedalium murex Linn.: an overview of its phytopharmacological aspects. Asian Pac J Trop Med. 2011b;4(9):748–755.
   PubMed Web of Science ®Google Scholar
• Shariff ZU. Modern herbal therapy for common ailments. [place unknown]: Spectrum Books; 2001.
   Google Scholar
• Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol. 2005;4(7):685–688.
   Web of Science ®Google Scholar
• Chen L, Teng H, Xie Z, Cao H, Cheang WS, Skalicka-Woniak K, et al. Modifications of dietary flavonoids towards improved bioactivity: an update on structure–activity relationship. Crit Rev Food Sci Nutr. 2018;58(4):513–527.
   PubMed Web of Science ®Google Scholar
• Halake K, Birajdar M, Lee J. Structural implications of polyphenolic antioxidants. J Indus Eng Chem. 2016;35:1–7.
   Web of Science ®Google Scholar
• Ito T, Fujimoto S, Suito F, Shimosaka M, Taguchi G. C-glycosyltransferases catalyzing the formation of di-C-glucosyl flavonoids in citrus plants. Plant J. 2017;91(2):187–198.
   PubMed Web of Science ®Google Scholar
• Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004;36(7):838–849.
   PubMed Web of Science ®Google Scholar
• Grayer RJ, Veitch NC. Flavanones and dihydroflavonols. Flavonoids: Chem Biochem Appl. 2006: 917–1002.
   Google Scholar
• Rimbach G, De Pascual-Teresa S, Ewins BA, Matsugo S, Uchida Y, Minihane A-M, et al. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica. 2003;33(9):913–925.
   PubMed Web of Science ®Google Scholar
• Pannala A, Rice-Evans CA, Halliwell B, Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun. 1997;232(1):164–168.
   PubMed Web of Science ®Google Scholar
• Heijnen CGM, Haenen G, Van Acker FAA, Van der Vijgh WJF, Bast A. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol in Vitro. 2001;15(1):3–6.
   PubMed Web of Science ®Google Scholar
• Hughes LAE, Arts ICW, Ambergen T, Brants HAM, Dagnelie PC, Goldbohm RA, et al. Higher dietary flavone, flavonol, and catechin intakes are associated with less of an increase in BMI over time in women: a longitudinal analysis from The Netherlands cohort study. Am J Clin Nutr. 2008;88(5):1341–1352.
   PubMed Web of Science ®Google Scholar
• Ho PC, Saville DJ, Coville PF, Wanwimolruk S. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharm Acta Helv. 2000;74(4):379–385.
   PubMedGoogle Scholar
• Gel-Moreto N, Streich R, Galensa R. Chiral separation of diastereomeric flavanone-7-O-glycosides in citrus by capillary electrophoresis. Electrophoresis. 2003;24(15):2716–2722.
   PubMed Web of Science ®Google Scholar
• Sung Y-Y, Kim D-S, Yang W-K, Nho KJ, Seo HS, Kim YS, Kim HK. Inhibitory effects of drynaria fortunei extract on house dust mite antigen-induced atopic dermatitis in NC/Nga mice. J Ethnopharmacol. 2012;144(1):94–100.
   PubMed Web of Science ®Google Scholar
• Gattuso G, Barreca D, Gargiulli C, Leuzzi U, Caristi C. Flavonoid composition of citrus juices. Molecules. 2007;12(8):1641–1673.
   PubMed Web of Science ®Google Scholar
• Llorach R, Martínez-Sánchez A, Tomás-Barberán FA, Gil MI, Ferreres F. Characterisation of polyphenols and antioxidant properties of five lettuce varieties and escarole. Food Chem. 2008;108(3):1028–1038.
   PubMed Web of Science ®Google Scholar
• Vallverdu-Queralt A, Odriozola-Serrano I, Oms-Oliu G, Lamuela-Raventós RM, Elez-Martinez P, Martin-Belloso O. Changes in the polyphenol profile of tomato juices processed by pulsed electric fields. J Agric Food Chem. 2012;60(38):9667–9672.
   PubMed Web of Science ®Google Scholar
• Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI. Antioxidant polyphenols from tart cherries (prunus cerasus). J Agric Food Chem. 1999;47(3):840–844.
   PubMed Web of Science ®Google Scholar
• Hungria M, Johnston AWB, Phillips DA. Effects of flavonoids released naturally from bean (Phaseolus vulgaris) on nodD-regulated gene transcription in rhizobium leguminosarum bv. phaseoli. Mol Plant Microbe Interact. 1992;5(3):199–203.
   PubMed Web of Science ®Google Scholar
• Sánchez-Rabaneda F, Jáuregui O, Casals I, Andrés-Lacueva C, Izquierdo-Pulido M, Lamuela-Raventós RM. Liquid chromatographic/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (theobroma cacao). J Mass Spectrometry. 2003;38(1):35–42.
   PubMed Web of Science ®Google Scholar
• Olsen HT, Stafford GI, Van Staden J, Christensen SB, Jäger AK. Isolation of the MAO-inhibitor naringenin from mentha aquatica L. J Ethnopharmacol. 2008;117(3):500–502.
   PubMed Web of Science ®Google Scholar
• Exarchou V, Godejohann M, van Beek TA, Gerothanassis IP, Vervoort J. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano. Anal Chem. 2003;75(22):6288–6294.
   PubMed Web of Science ®Google Scholar
• Yao LH, Jiang Y-M, Shi J, Tomas-Barberan FA, Datta N, Singanusong R, Chen SS. Flavonoids in food and their health benefits. Plant Foods Human Nutrition. 2004;59:113–122.
   PubMed Web of Science ®Google Scholar
• Graf BA, Milbury PE, Blumberg JB. Flavonols, flavones, flavanones, and human health: epidemiological evidence. J Med Food. 2005;8(3):281–290.
   PubMed Web of Science ®Google Scholar
• Tripoli E, La Guardia M, Giammanco S, Di Majo D, Giammanco M. Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chem. 2007;104(2):466–479.
   Web of Science ®Google Scholar
• Nouri Z, Fakhri S, El-Senduny FF, Sanadgol N, Abd-ElGhani GE, Farzaei MH, Chen J-T. On the neuroprotective effects of naringenin: pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective. Biomolecules. 2019;9(11):690.
   PubMed Web of Science ®Google Scholar
• Zobeiri M, Belwal T, Parvizi F, Naseri R, Farzaei MH, Nabavi SF, et al. Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective. Curr Pharm Biotechnol. 2018;19(3):196–205.
   PubMed Web of Science ®Google Scholar
• Justesen U, Knuthsen P, Leth T. Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J Chromatogr A. 1998;799(1–2):101–110.
   PubMed Web of Science ®Google Scholar
• Garg A, Garg S, Zaneveld LJD, Singla AK. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytotherapy Res. 2001;15(8):655–669.
   PubMed Web of Science ®Google Scholar
• Zhang L, Song L, Zhang P, Liu T, Zhou L, Yang G, et al. Solubilities of naringin and naringenin in different solvents and dissociation constants of naringenin. J Chem Eng Data. 2015;60(3):932–940.
   Web of Science ®Google Scholar
• Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003;57(2):235–242.
   PubMed Web of Science ®Google Scholar
• Andersen OM, Markham KR. Flavonoids: chemistry, biochemistry and applications. [place unknown]: CRC press; 2005.
   Google Scholar
• Harborne JB.. The flavonoids: advances in research since 1980. New York (NY): Springer; 2013.
   Google Scholar
• Hernández-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: molecular mechanisms. World J Gastroenterol. 2018;24(16):1679.
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 1996;20(7):933–956.
   PubMed Web of Science ®Google Scholar
• Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 2002;13(10):572–584.
   PubMed Web of Science ®Google Scholar
• Yanez JA, Andrews PK, Davies NM. Methods of analysis and separation of chiral flavonoids. J Chromatogr B. 2007;848(2):159–181.
   PubMed Web of Science ®Google Scholar
• Krause M, Galensa R. Analysis of enantiomeric flavanones in plant extracts by high-performance liquid chromatography on a cellulose triacetate based chiral stationary phase. Chromatographia. 1991;32:69–72.
   Web of Science ®Google Scholar
• Wistuba D, Trapp O, Gel-Moreto N, Galensa R, Schurig V. Stereoisomeric separation of flavanones and flavanone-7-O-glycosides by capillary electrophoresis and determination of interconversion barriers. Anal Chem. 2006;78(10):3424–3433.
   PubMed Web of Science ®Google Scholar
• Gaggeri R, Rossi D, Collina S, Mannucci B, Baierl M, Juza M. Quick development of an analytical enantioselective high performance liquid chromatography separation and preparative scale-up for the flavonoid naringenin. J Chromatogr A. 2011;1218(32):5414–5422.
   PubMed Web of Science ®Google Scholar
• Peterson J, Dwyer J. Flavonoids: dietary occurrence and biochemical activity. Nutr Res. 1998;18(12):1995–2018.
   Web of Science ®Google Scholar
• Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22(1):19–34.
   PubMed Web of Science ®Google Scholar
• Renugadevi J, Prabu SM. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology. 2009;256(1–2):128–134.
   PubMed Web of Science ®Google Scholar
• Jung UJ, Kim HJ, Lee JS, Lee MK, Kim HO, Park EJ, et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 2003;22(6):561–568.
   PubMed Web of Science ®Google Scholar
• Álvarez-Álvarez R, Botas A, Albillos SM, Rumbero A, Martín JF, Liras P. Molecular genetics of naringenin biosynthesis, a typical plant secondary metabolite produced by streptomyces clavuligerus. Microb Cell Fact. 2015;14(1):1–12.
   PubMedGoogle Scholar
• Wang Q, Yang J, Zhang X, Zhou L, Liao X-L, Yang B. Practical synthesis of naringenin. J Chem Res. 2015;39(8):455–457.
   Google Scholar
• Karim N, Jia Z, Zheng X, Cui S, Chen W. A recent review of citrus flavanone naringenin on metabolic diseases and its potential sources for high yield-production. Trends Food Sci Technol. 2018;79:35–54.
   Web of Science ®Google Scholar
• Koopman F, Beekwilder J, Crimi B, van Houwelingen A, Hall RD, Bosch D, et al. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae. Microb Cell Fact. 2012;11:1–15.
   PubMed Web of Science ®Google Scholar
• Pandey RP, Parajuli P, Koffas MAG, Sohng JK. Microbial production of natural and non-natural flavonoids: pathway engineering, directed evolution and systems/synthetic biology. Biotechnol Adv. 2016;34(5):634–662.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu H, Li X, Liu D, Dong XT, Li FF, Yuan YJ. Production of naringenin from D-xylose with co-culture of E. coli and S. cerevisiae. Eng Life Sci. 2017;17(9):1021–1029.
   PubMed Web of Science ®Google Scholar
• Qian X, Chen L, Sui Y, Chen C, Zhang W, Zhou J, et al. Biotechnological potential and applications of microbial consortia. Biotechnol Adv. 2020;40:107500.
   PubMed Web of Science ®Google Scholar
• Joshi M, Singh S, Patel S, Shah D, Krishnakumar A. Identification of small molecule activators for ErbB 4 receptor to enhance oligodendrocyte regeneration by in silico approach. Comput Toxicol. 2018a;8:13–20.
   Google Scholar
• Otobone FJ, Sanches ACC, Nagae R, Martins JVC, Sela VR, de Mello JCP, Audi EA. Effect of lyophilized extracts from guaraná seeds [paullinia cupana var. sorbilis (mart.) ducke] on behavioral profiles in rats. Phytotherapy Res: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2007;21(6):531–535.
   Google Scholar
• Chabane MN, Al AA, Peluso J, Muller CD, Ubeaud-Séquier G. Quercetin and naringenin transport across human intestinal caco-2 cells. J Pharm Pharmacol. 2009;61(11):1473–1483.
   PubMed Web of Science ®Google Scholar
• Xu H, Kulkarni KH, Singh R, Yang Z, Wang SWJ, Tam VH, Hu M. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. Mol Pharm. 2009;6(6):1703–1715.
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr. 2007;61(4):472–477.
   PubMed Web of Science ®Google Scholar
• Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood–brain barrier: in vitro studies. J Neurochem. 2003;85(1):180–192.
   PubMed Web of Science ®Google Scholar
• Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood–brain barrier. Free Radic Biol Med. 2004;36(5):592–604.
   PubMed Web of Science ®Google Scholar
• Peng HW, Cheng FC, Huang YT, Chen CF, Tsai TH. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1998;714(2):369–374.
   PubMed Web of Science ®Google Scholar
• Felgines C, Texier O, Morand C, Manach C, Scalbert A, Régerat F, Rémésy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol-Gastrointestinal Liver Physiol. 2000;279(6):G1148–G1154.
   PubMed Web of Science ®Google Scholar
• El Mohsen MA, Marks J, Kuhnle G, Rice-Evans C, Moore K, Gibson G, et al. The differential tissue distribution of the citrus flavanone naringenin following gastric instillation. Free Radic Res. 2004;38(12):1329–1340.
   PubMed Web of Science ®Google Scholar
• Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr. 2001;131(2):235–241.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhu S, Yang W, Huang Q, Ho CT. The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems. Food Funct. 2021;12(8):3307–3323.
   PubMed Web of Science ®Google Scholar
• Otake Y, Walle T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metabol Disposition. 2002;30(2):103–105.
   PubMed Web of Science ®Google Scholar
• Nikolic D, van Breemen RB. New metabolic pathways for flavanones catalyzed by rat liver microsomes. Drug Metabol Disposition. 2004;32(4):387–397.
   PubMed Web of Science ®Google Scholar
• Wittemer SM, Ploch M, Windeck T, Müller SC, Drewelow B, Derendorf H, Veit M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomedicine. 2005;12(1-2):28–38.
   PubMed Web of Science ®Google Scholar
• Koga N, Ohta C, Kato Y, Haraguchi K, Endo T, Ogawa K, Yano M. In vitro metabolism of nobiletin, a polymethoxy-flavonoid, by human liver microsomes and cytochrome P450. Xenobiotica. 2011;41(11):927–933.
   PubMed Web of Science ®Google Scholar
• Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther. 1995;58(4):365–373.
   PubMed Web of Science ®Google Scholar
• Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL. Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther. 1996;60(1):34–40.
   PubMed Web of Science ®Google Scholar
• Lee YS, Reidenberg MM. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man. Pharmacology. 1998;56(6):314–317.
   PubMed Web of Science ®Google Scholar
• Kay CD, Pereira-Caro G, Ludwig IA, Clifford MN, Crozier A. Anthocyanins and flavanones are more bioavailable than previously perceived: a review of recent evidence. Annu Rev Food Sci Technol. 2017;8:155–180.
   PubMed Web of Science ®Google Scholar
• González-Sarrías A, Espín JC, Tomás-Barberán FA. Non-extractable polyphenols produce gut microbiota metabolites that persist in circulation and show anti-inflammatory and free radical-scavenging effects. Trends Food Sci Tech. 2017;69:281–288.
   Web of Science ®Google Scholar
• Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204–219.
   PubMed Web of Science ®Google Scholar
• Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, Benveniste EN. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol. 2007;179(9):5966–5976.
   PubMed Web of Science ®Google Scholar
• Tejera D, Heneka MT. Microglia in neurodegenerative disorders. Microglia: Methods Protocols. 2019;18:57–67.
   Google Scholar
• Voet S, Mc Guire C, Hagemeyer N, Martens A, Schroeder A, Wieghofer P, et al. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nat Commun. 2018;9(1):256–265.
   PubMedGoogle Scholar
• Choi JK, Dambuza IM, He C, Yu CR, Uche AN, Mattapallil MJ, et al. IL-12p35 inhibits neuroinflammation and ameliorates autoimmune encephalomyelitis. Front Immunol. 2017;8:10–12.
   PubMed Web of Science ®Google Scholar
• Wang J, Qi Y, Niu X, Tang H, Meydani SN, Wu D. Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice. J Nutr Biochem. 2018b;54:130–139.
   PubMed Web of Science ®Google Scholar
• Khajevand-Khazaei M-R, Ziaee P, Motevalizadeh S-A, Rohani M, Afshin-Majd S, Baluchnejadmojarad T, Roghani M. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat. Eur J Pharmacol. 2018;826:114–122.
   PubMed Web of Science ®Google Scholar
• Heo HJ, Kim D-O, Shin SC, Kim MJ, Kim BG, Shin D-H. Effect of antioxidant flavanone, naringenin, from citrus junos on neuroprotection. J Agric Food Chem. 2004a;52(6):1520–1525.
   PubMed Web of Science ®Google Scholar
• Shi L-B, Tang P-F, Zhang W, Zhao Y-P, Zhang L-C, Zhang H. Naringenin inhibits spinal cord injury-induced activation of neutrophils through miR-223. Gene. 2016;592(1):128–133.
   PubMed Web of Science ®Google Scholar
• Park HY, Kim G-Y, Choi YH. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases. Int J Mol Med. 2012;30(1):204–210.
   PubMed Web of Science ®Google Scholar
• Wu L-H, Lin C, Lin H-Y, Liu Y-S, Wu CY-J, Tsai C-F, et al. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression. Mol Neurobiol. 2016;53:1080–1091.
   PubMed Web of Science ®Google Scholar
• Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JPE. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys. 2009;484(1):100–109.
   PubMed Web of Science ®Google Scholar
• Raza SS, Khan MM, Ahmad A, Ashafaq M, Islam F, Wagner AP, Safhi MM. Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke. Neuroscience. 2013;230:157–171.
   PubMed Web of Science ®Google Scholar
• Pinho-Ribeiro FA, Zarpelon AC, Fattori V, Manchope MF, Mizokami SS, Casagrande R, Verri Jr WA. Naringenin reduces inflammatory pain in mice. Neuropharmacology. 2016;105:508–519.
   PubMed Web of Science ®Google Scholar
• Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, Clouthier SG, et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene. 2015;34(6):671–680.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hou X, Yang S. Lidocaine potentiates SOCS3 to attenuate inflammation in microglia and suppress neuropathic pain. Cell Mol Neurobiol. 2019;39:1081–1092.
   PubMed Web of Science ®Google Scholar
• Bair AM, Thippegowda PB, Freichel M, Cheng N, Richard DY, Vogel SM, et al. Ca2 + entry via TRPC channels is necessary for thrombin-induced NF-κB activation in endothelial cells through AMP-activated protein kinase and protein kinase Cδ. J Biol Chem. 2009;284(1):563–574.
   PubMed Web of Science ®Google Scholar
• Gautam S, Ishrat N, Yadav P, Singh R, Narender T, Srivastava AK. 4-Hydroxyisoleucine attenuates the inflammation-mediated insulin resistance by the activation of AMPK and suppression of SOCS-3 coimmunoprecipitation with both the IR-β subunit as well as IRS-1. Mol Cell Biochem. 2016;414:95–104.
   PubMed Web of Science ®Google Scholar
• Yang P, Sun F. Aducanumab: the first targeted Alzheimer's therapy. Drug Discover Therapeut. 2021;15(3):166–168.
   PubMed Web of Science ®Google Scholar
• Navipour E, Mahbobeh N, Barabadi Z, Mohammad N, Keykhosravi A. Epidemiology and risk factors of Alzheimer's disease in Iran: a systematic review. Iran J Public Health. 2019;48(12):2133–2140.
   PubMed Web of Science ®Google Scholar
• Alzheimer's Association 2009 Alzheimer's Disease Facts and Figures. Available at: www.alz.org/alzheimers_disease_facts_figures.asp; report_alzfactsfigures2009.pdf; and www.alz.org/news_and_events_2009_facts_figures.asp Accessed February 8, 2010.
   Google Scholar
• Kumar Vats D, Biswas N, Pandian P, Kamalakannan A. Review current and emerging treatment options for Alzheimer's disease. Neurol Lett. 2023;2(1):1–5.
   Google Scholar
• Thrall JH. Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness. Radiology. 2005;235(1):9–12.
   PubMed Web of Science ®Google Scholar
• Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol. 2006;199(2):265–273.
   PubMed Web of Science ®Google Scholar
• Feng G, Wang W, Qian Y, Jin H. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1–40. J Neurosci Methods. 2013;218(1):48–54.
   PubMed Web of Science ®Google Scholar
• Zhang F, Jiang L. Neuroinflammation in Alzheimer's disease. Neuropsychiatr Dis Treat. 2015;17-25:243–256.
   Google Scholar
• Bona DD, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Vasto S. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications. Curr Pharmaceut Des. 2010;16(6):684–691.
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhao B, Ratka A. Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromol Med. 2011;13:223–250.
   PubMed Web of Science ®Google Scholar
• Rajmohan R, Reddy PH. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons. J Alzheimer's Dis. 2017;57(4):975–999.
   PubMed Web of Science ®Google Scholar
• Jin H, Wang W, Zhao S, Yang W, Qian Y, Jia N, Feng G. Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice. Vaccine. 2014;32(35):4450–4456.
   PubMed Web of Science ®Google Scholar
• Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377(9770):1019–1031.
   PubMed Web of Science ®Google Scholar
• Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168–181.
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Tong M, Daiello LA, Ott BR. Early-stage Alzheimer's disease is associated with simultaneous systemic and central nervous system dysregulation of insulin-linked metabolic pathways. J Alzheimer's Dis. 2019;68(2):657–668.
   PubMed Web of Science ®Google Scholar
• Fakhri S, Abbaszadeh F, Dargahi L, Jorjani M. Astaxanthin: a mechanistic review on its biological activities and health benefits. Pharmacol Res. 2018a;136:1–20.
   PubMed Web of Science ®Google Scholar
• Fakhri S, Dargahi L, Abbaszadeh F, Jorjani M. Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury. Brain Res Bull. 2018b;143:217–224.
   PubMed Web of Science ®Google Scholar
• Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Neurolog Sci. 2014;35:741–751.
   PubMed Web of Science ®Google Scholar
• Variya BC, Bakrania AK, Patel SS. Antidiabetic potential of gallic acid from emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling. Phytomedicine. 2020;73:336–345.
   Web of Science ®Google Scholar
• Zhang N, Hu Z, Zhang Z, Liu G, Wang Y, Ren Y, et al. Protective role of naringenin against Aβ 25-35-caused damage via ER and PI3K/Akt-mediated pathways. Cell Mol Neurobiol. 2018;38:549–557.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kuboyama T, Tohda C. A systematic strategy for discovering a therapeutic drug for Alzheimer's disease and its target molecule. Front Pharmacol. 2017;340:721–735.
   Google Scholar
• Ip JP, Fu AK, Ip NY. CRMP2: functional roles in neural development and therapeutic potential in neurological diseases. Neuroscientist. 2014;20(6):589–598.
   PubMed Web of Science ®Google Scholar
• Wilson SM, Ki Yeon S, Yang X-F, Park KD, Khanna R.. Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ss and CDK5 following traumatic brain injury. Front Cell Neurosci. 2014;8:135–142.
   PubMed Web of Science ®Google Scholar
• Sumi T, Imasaki T, Aoki M, Sakai N, Nitta E, Shirouzu M, Nitta R. Structural insights into the altering function of CRMP2 by phosphorylation. Cell Struct Funct. 2018;43(1):15–23.
   PubMed Web of Science ®Google Scholar
• Zambrano P, Suwalsky M, Jemiola-Rzeminska M, Strzalka K, Sepúlveda B, Gallardo MJ, Aguilar LF. The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes. Biochim Biophys Acta (BBA)-Biomembranes. 2019;1861(6):1078–1085.
   PubMed Web of Science ®Google Scholar
• Assefa AD, Saini RK, Keum YS. Extraction of antioxidants and flavonoids from yuzu (citrus junos sieb ex tanaka) peels: a response surface methodology study. J Food Measure Characterization. 2017;11:364–379.
   Web of Science ®Google Scholar
• Heo HJ, Kim M-J, Lee J-M, Choi SJ, Cho H-Y, Hong B, et al. Naringenin from citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement Geriatr Cogn Disord. 2004b;17(3):151–157.
   PubMed Web of Science ®Google Scholar
• Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis. 2002;10(3):279–288.
   PubMed Web of Science ®Google Scholar
• Ciro A, Park J, Burkhard G, Yan N, Geula C. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex. Curr Alzheimer Res. 2012;9(1):138–143.
   PubMed Web of Science ®Google Scholar
• Lee S, Youn K, Lim G, Lee J, Jun M. In silico docking and in vitro approaches towards BACE1 and cholinesterases inhibitory effect of citrus flavanones. Molecules. 2018;23(7):332–345.
   PubMed Web of Science ®Google Scholar
• Khan MB, Khan MM, Khan A, Ahmed ME, Ishrat T, Tabassum R, et al. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem Int. 2012;61(7):1081–1093.
   PubMed Web of Science ®Google Scholar
• Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in huntington's disease mice. Neuroscience. 2008;157(1):280–295.
   PubMed Web of Science ®Google Scholar
• Bano D, Zanetti F, Mende Y, Nicotera P. Neurodegenerative processes in huntington's disease. Cell Death Dis. 2011;2(11):e228–e228.
   PubMedGoogle Scholar
• Yamagishi N, Yamamoto Y, Noda C, Hatayama T. Naringenin inhibits the aggregation of expanded polyglutamine tract-containing protein through the induction of endoplasmic reticulum chaperone GRP78. Biol Pharm Bull. 2012;35(10):1836–1840.
   PubMed Web of Science ®Google Scholar
• Brouillet E, Jacquard C, Bizat N, Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in huntington's disease. J Neurochem. 2005;95(6):1521–1540.
   PubMed Web of Science ®Google Scholar
• Amin I, Majid S, Farooq A, Wani HA, Noor F, Khan R, et al. Naringenin (4, 5, 7-trihydroxyflavanone) as a potent neuroprotective agent: from chemistry to medicine. Stud Natural Prod Chem. 2020;65:271–300.
   Google Scholar
• Daneman R, Prat A. The blood–brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):345–351.
   Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic B V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–150.
   PubMed Web of Science ®Google Scholar
• Salman M, Sharma P, Alam MI, Tabassum H, Parvez S. Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced huntington's disease like symptoms in rats. Nutritional Neurosci. 2022a;25(9):1898–1908.
   PubMed Web of Science ®Google Scholar
• Guimaraes AG, Gomes SVF, Moraes VRS, Nogueira PCL, Ferreira AG, Blank AF, et al. Phytochemical characterization and antinociceptive effect of lippia gracilis schauer. J Nat Med. 2012;66:428–434.
   PubMed Web of Science ®Google Scholar
• Braidy N, Grant R, Adams S, Guillemin GJ. Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J. 2010;277(2):368–382.
   PubMed Web of Science ®Google Scholar
• McGowan DP, van Roon-Mom W, Holloway H, Bates GP, Mangiarini L, Cooper GJS, et al. Amyloid-like inclusions in Huntington's disease. Neuroscience. 2000;100(4):677–680.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res. 2010;206(1):38–46.
   PubMed Web of Science ®Google Scholar
• Savitt JM, Dawson VL, Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006;116(7):1744–1754.
   PubMed Web of Science ®Google Scholar
• Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol: Mech Dis. 2011;6:193–222.
   PubMed Web of Science ®Google Scholar
• Burke RE, O'Malley K. Axon degeneration in Parkinson's disease. Exp Neurol. 2013;246:72–83.
   PubMed Web of Science ®Google Scholar
• Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005;57(2):168–175.
   PubMed Web of Science ®Google Scholar
• Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxidative Med Cellular Longevity. 2012;2012:564–572.
   Google Scholar
• Abramov AY, Potapova EV, Dremin VV, Dunaev AV. Interaction of oxidative stress and misfolded proteins in the mechanism of neurodegeneration. Life. 2020;10(7):401–411.
   Google Scholar
• Jayaraj RL, Beiram R, Azimullah S, Meeran MFN, Ojha SK, Adem A, et al. Lycopodium attenuates loss of dopaminergic neurons by suppressing oxidative stress and neuroinflammation in a rat model of Parkinson's disease. Molecules. 2019;24(11):456–466.
   PubMed Web of Science ®Google Scholar
• Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, et al. Novel immunotherapeutic approaches to target alpha-synuclein and related neuroinflammation in Parkinson's disease. Cells. 2019;8(2):891–906.
   PubMed Web of Science ®Google Scholar
• Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson's disease. Front Neuroana. 2015;9:1011–1023.
   Web of Science ®Google Scholar
• Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27–42.
   PubMed Web of Science ®Google Scholar
• Li J, Long X, Hu J, Bi J, Zhou T, Guo X, et al. Multiple pathways for natural product treatment of Parkinson's disease: a mini review. Phytomedicine. 2019;60:782–791.
   Web of Science ®Google Scholar
• Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway. Neuropharmacology. 2014;79:380–388.
   PubMed Web of Science ®Google Scholar
• Pascua-Maestro R, González E, Lillo C, Ganfornina MD, Falcón-Pérez JM, Sanchez D. Extracellular vesicles secreted by astroglial cells transport apolipoprotein D to neurons and mediate neuronal survival upon oxidative stress. Front Cell Neurosci. 2019;12:102–111.
   Web of Science ®Google Scholar
• Wang G-Q, Zhang B, He X-M, Li D-D, Shi J-S, Zhang F. Naringenin targets on astroglial Nrf2 to support dopaminergic neurons. Pharmacol Res. 2019;139:452–459.
   PubMed Web of Science ®Google Scholar
• Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. 2005;39(10):1119–1125.
   PubMed Web of Science ®Google Scholar
• Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Wolozin B. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin, and DJ-1 in caenorhabditis elegans. J Biol Chem. 2005;280(52):42655–42668.
   PubMed Web of Science ®Google Scholar
• Song S, Jang S, Park J, Bang S, Choi S, Kwon KY, Chung J. Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila. J Biol Chem. 2013;288(8):5660–5672.
   PubMed Web of Science ®Google Scholar
• Guo L, Gandhi PN, Wang W, Petersen RB, Wilson-Delfosse AL, Chen SG. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res. 2007;313(16):3658–3670.
   PubMed Web of Science ®Google Scholar
• Haavik J, Toska K. Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol. 1998;16:285–309.
   PubMed Web of Science ®Google Scholar
• Angeline MS, Sarkar A, Anand K, Ambasta RK, Kumar P. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model. Neuroscience. 2013;254:379–394.
   PubMed Web of Science ®Google Scholar
• Wegrzynowicz M, Bar-On D, Calo' L, Anichtchik O, Iovino M, Xia J, et al. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Acta Neuropathol. 2019;138:575–595.
   PubMed Web of Science ®Google Scholar
• Mani S, Sekar S, Barathidasan R, Manivasagam T, Thenmozhi AJ, Sevanan M, et al. Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson's disease model in mice. Neurotox Res. 2018a;33:656–670.
   PubMed Web of Science ®Google Scholar
• Sugumar M, Sevanan M, Sekar S. Neuroprotective effect of naringenin against MPTP-induced oxidative stress. Int J Neurosci. 2019;129(6):534–539.
   PubMed Web of Science ®Google Scholar
• Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015;14(4):406–419.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Jang M, Choi J, Chang BS, Kim DY, Kim S-H, et al. Korean red ginseng and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Mol Neurobiol. 2016;53:1977–2002.
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Zoheir KMA, Abdel-Hamied HE, Ashour AE, Bakheet SA, Attia SM, Abd-Allah ARA. Amelioration of autoimmune arthritis by naringin through modulation of T regulatory cells and Th1/Th2 cytokines. Cell Immunol. 2014;287(2):112–120.
   PubMed Web of Science ®Google Scholar
• Sánchez-López AL, Ortiz GG, Pacheco-Moises FP, Mireles-Ramírez MA, Bitzer-Quintero OK, Delgado-Lara DLC, et al. Efficacy of melatonin on serum pro-inflammatory cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch Med Res. 2018;49(6):391–398.
   PubMed Web of Science ®Google Scholar
• Wang J, Niu X, Wu C, Wu D. Naringenin modifies the development of lineage-specific effector CD4+ T cells. Front Immunol. 2018a;9:209–219.
   PubMed Web of Science ®Google Scholar
• Xie L, Gong W, Chen J, Xie H, Wang M, Yin X, Wu W. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation. Int Immunopharmacol. 2018;62:227–236.
   PubMed Web of Science ®Google Scholar
• de Araújo Farias V, Carrillo-Gálvez AB, Martin F, Anderson P. TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer. Cytokine Growth Factor Rev. 2018;43:25–37.
   PubMed Web of Science ®Google Scholar
• Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK. Retinoic acid increases Foxp3 + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol. 2008;181(4):2277–2284.
   PubMed Web of Science ®Google Scholar
• Niu X, Wu C, Li M, Zhao Q, Meydani SN, Wang J, Wu D. Naringenin is an inhibitor of T cell effector functions. J Nutr Biochem. 2018;58:71–79.
   PubMed Web of Science ®Google Scholar
• Zhan Z, Song L, Zhang W, Gu H, Cheng H, Zhang Y, et al. Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability. Cell Death Dis. 2019:10(4):209–215.
   Google Scholar
• Lee Y, Lahens NF, Zhang S, Bedont J, Field JM, Sehgal A. G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLoS Biol. 2019;17(4):562–572.
   Web of Science ®Google Scholar
• Proost P, Struyf S, Van Damme J, Fiten P, Ugarte-Berzal E, Opdenakker G. Chemokine isoforms and processing in inflammation and immunity. J Autoimmun. 2017;85:45–57.
   PubMed Web of Science ®Google Scholar
• Galvez-Contreras AY, Quiñones-Hinojosa A, Gonzalez-Perez O. The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. Front Cell Neurosci. 2013;7:435–444.
   Web of Science ®Google Scholar
• Aguirre A, Dupree JL, Mangin JM, Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci. 2007;10(8):990–1002.
   PubMed Web of Science ®Google Scholar
• Joshi R, Kulkarni YA, Wairkar S. Pharmacokinetic, pharmacodynamic and formulations aspects of naringenin: an update. Life Sci. 2018b;215: 43-56.
   PubMed Web of Science ®Google Scholar
• Sveinsson OA, Kjartansson O, Valdimarsson EM. Cerebral ischemia/infarction-diagnosis and treatment. Laeknabladid. 2014;100(7–8):393–401.
   PubMed Web of Science ®Google Scholar
• Yang J, Yuan L, Wen Y, Zhou H, Jiang W, Xu D, Wang M. Protective effects of naringin in cerebral infarction and its molecular mechanism. Med Sci Monit. 2020;26:e918772–1.
   PubMed Web of Science ®Google Scholar
• Olmez I, Ozyurt H. Reactive oxygen species and ischemic cerebrovascular disease. Neurochem Int. 2012;60(2):208–212.
   PubMed Web of Science ®Google Scholar
• Fukui M, Choi HJ, Zhu BT. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med. 2010;49(5):800–813.
   PubMed Web of Science ®Google Scholar
• Egbuonu ACC, Obidoa O, Ezeokonkwo CA, Ejikeme PM. Hepatotoxic effects of low dose oral administration of monosodium glutamate in male albino rats. Afr J Biotechnol. 2009;8:562–571.
   Google Scholar
• Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci. 2001;98(20):11569–11574.
   PubMed Web of Science ®Google Scholar
• Xu X-H, Ma C-M, Han Y-Z, Li Y, Liu C, Duan Z-H, et al. Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells. Arch Biol Sci. 2015;67(2):639–646.
   Google Scholar
• Kara S, Gencer B, Karaca T, Tufan HA, Arikan S, Ersan I, et al. Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. Scientific World J. 2014;2014:15–23.
   Google Scholar
• Bai X, Zhang X, Chen L, Zhang J, Zhang L, Zhao X, et al. Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression. Neurochem Res. 2014;39:1405–1415.
   PubMed Web of Science ®Google Scholar
• Drishya S, Dhanisha SS, Raghukumar P, Guruvayoorappan C. Amomum subulatum mitigates total body irradiation-induced oxidative stress and its associated inflammatory response by enhancing the antioxidant status and regulating the pro-inflammatory cytokines. J Nutr Biochem. 2022;107:25–31.
   Web of Science ®Google Scholar
• Saleh TM, Saleh MC, Connell BJ, Song Y. A co-drug conjugate of naringenin and lipoic acid mediates neuroprotection in a rat model of oxidative stress. Clin Exp Pharmacol Physiol. 2017;44(10):1008–1016.
   PubMed Web of Science ®Google Scholar
• Pathan AR, Viswanad B, Sonkusare SK, Ramarao P. Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 2006;79(23):2209–2216.
   PubMed Web of Science ®Google Scholar
• Ren B, Qin W, Wu F, Wang S, Pan C, Wang L, et al. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur J Pharmacol. 2016;773:13–23.
   PubMed Web of Science ®Google Scholar
• Hong Y, Yin Y, Tan Y, Hong K, Zhou H.. The flavanone, naringenin, modifies antioxidant and steroidogenic enzyme activity in a rat model of letrozole-induced polycystic ovary syndrome. Med Sci Monit. 2019;25:27–33.
   Web of Science ®Google Scholar
• Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience. 2012;226:62–72.
   PubMed Web of Science ®Google Scholar
• Baluchnejadmojarad T, Roghani M. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology. 2006;78(4):193–197.
   PubMed Web of Science ®Google Scholar
• Upadhyay P, Sadhu A, Singh PK, Agrawal A, Ilango K, Purohit S, Dubey GP. Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in rats. Biomed Pharmacother. 2018;97:1046–1052.
   PubMed Web of Science ®Google Scholar
• Liaquat L, Batool Z, Sadir S, Rafiq S, Shahzad S, Perveen T, Haider S. Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats. Life Sci. 2018;194:213–223.
   PubMed Web of Science ®Google Scholar
• Zaki HF, Abd-El-Fattah MA, Attia AS. Naringenin protects against scopolamine-induced dementia in rats. Bull Faculty Pharmacy, Cairo University. 2014;52(1):15–25.
   Google Scholar
• Li Y, Zeng M, Chen W, Liu C, Wang F, Han X, et al. Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats. PLoS One. 2014;9(4):35–41.
   Web of Science ®Google Scholar
• Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009;8(8):627–644.
   PubMed Web of Science ®Google Scholar
• Hua F-Z, Ying J, Zhang J, Wang X-F, Hu Y-H, Liang Y-P, et al. Naringenin pre-treatment inhibits neuroapoptosis and ameliorates cognitive impairment in rats exposed to isoflurane anesthesia by regulating the PI3/Akt/PTEN signalling pathway and suppressing NF-κB-mediated inflammation. Int J Mol Med. 2016;38(4):1271–1280.
   PubMed Web of Science ®Google Scholar
• Ahshin-Majd S, Zamani S, Kiamari T, Kiasalari Z, Baluchnejadmojarad T, Roghani M. Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: possible involved mechanisms. Peptides (NY). 2016;86:102–111.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang W-Y, Mao Y-W, Gräff J, Guan J-S, Pan L, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010;466(7310):1105–1109.
   PubMed Web of Science ®Google Scholar
• Sarubbo F, Ramis MR, Kienzer C, Aparicio S, Esteban S, Miralles A, Moranta D. Chronic silymarin, quercetin and naringenin treatments increase monoamines synthesis and hippocampal Sirt1 levels improving cognition in aged rats. J Neuroimmune Pharmacol. 2018;13:24–38.
   PubMed Web of Science ®Google Scholar
• Farina M, Aschner M, Rocha JBT. Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol. 2011;256(3):405–417.
   PubMed Web of Science ®Google Scholar
• Mailloux RJ, Yumvihoze E, Chan HM. Superoxide produced in the matrix of mitochondria enhances methylmercury toxicity in human neuroblastoma cells. Toxicol Appl Pharmacol. 2015;289(3):371–380.
   PubMed Web of Science ®Google Scholar
• Sumathi T, Christinal J. Neuroprotective effect of portulaca oleraceae ethanolic extract ameliorates methylmercury induced cognitive dysfunction and oxidative stress in cerebellum and cortex of rat brain. Biol Trace Elem Res. 2016;172:155–165.
   PubMed Web of Science ®Google Scholar
• Chandran AMK, Christina H, Das S, Mumbrekar KD, Rao BSS.. Neuroprotective role of naringenin against methylmercury induced cognitive impairment and mitochondrial damage in a mouse model. Environ Toxicol Pharmacol. 2019;71:57–62.
   Web of Science ®Google Scholar
• Fagan AM, Christopher E, Taylor JW, Parsadanian M, Spinner M, Watson M, Holtzman DM. ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-β pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis. Am J Pathol. 2004;165(4):1413–1422.
   PubMed Web of Science ®Google Scholar
• Bahramsoltani R, Farzaei MH, Farahani MS, Rahimi R. Phytochemical constituents as future antidepressants: a comprehensive review. Rev Neurosci. 2015;26(6):699–719.
   PubMed Web of Science ®Google Scholar
• Ghofrani S, Joghataei M-T, Mohseni S, Baluchnejadmojarad T, Bagheri M, Khamse S, Roghani M. Naringenin improves learning and memory in an Alzheimer's disease rat model: insights into the underlying mechanisms. Eur J Pharmacol. 2015;764:195–201.
   PubMed Web of Science ®Google Scholar
• Ma J, Yang W-Q, Zha H, Yu H-R. Effect of naringenin on learning and memory ability on model rats with Alzheimer disease. Zhong Yao Cai. 2013;36(2):271–276.
   PubMedGoogle Scholar
• Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J. The neurotoxicity of iron, copper and manganese in Parkinson's and wilson's diseases. J Trace Elements Med Biol. 2015;31:193–203.
   PubMed Web of Science ®Google Scholar
• Kumar R, Jain V, Kushwah N, Dheer A, Mishra KP, Prasad D, Singh SB. Role of DNA methylation in hypobaric hypoxia-induced neurodegeneration and spatial memory impairment. Ann Neurosci. 2018;25:191–200.
   PubMed Web of Science ®Google Scholar
• Cheraghi G, Hajiabedi E, Niaghi B, Nazari F, Naserzadeh P, Hosseini M.. High doses of sodium tungstate can promote mitochondrial dysfunction and oxidative stress in isolated mitochondria. J Biochem Mol Toxicol. 2019;33(4):772–785.
   Web of Science ®Google Scholar
• Fakhri S, Dargahi L, Abbaszadeh F, Jorjani M. Effects of astaxanthin on sensory-motor function in a compression model of spinal cord injury: involvement of ERK and AKT signalling pathway. Eur J Pain. 2019;23(4):750–764.
   PubMed Web of Science ®Google Scholar
• Yao J, Peng S, Xu J, Fang J. Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway. BioFactors. 2019;45(4):616–626.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Angeline MS, Anand K, Ambasta RK, Kumar P. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model. Brain Res. 2012;1481:59–70.
   PubMed Web of Science ®Google Scholar
• Muthaiah VPK, Venkitasamy L, Michael FM, Chandrasekar K, Venkatachalam S. Neuroprotective role of naringenin on carbaryl induced neurotoxicity in mouse neuroblastoma cells. J Pharmacol Pharmacother. 2013;4(3):192–209.
   PubMedGoogle Scholar
• Chtourou Y, Fetoui H, Gdoura R. Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress. Biol Trace Elem Res. 2014;158:376–383.
   PubMed Web of Science ®Google Scholar
• Chtourou Y, Ben SA, Gdoura R, Fetoui H. Naringenin mitigates iron-induced anxiety-like behavioral impairment, mitochondrial dysfunctions, ectonucleotidases and acetylcholinesterase alteration activities in rat hippocampus. Neurochem Res. 2015;40:1563–1575.
   PubMed Web of Science ®Google Scholar
• Sachdeva S, Pant SC, Kushwaha P, Bhargava R, Flora SJS. Sodium tungstate induced neurological alterations in rat brain regions and their response to antioxidants. Food Chem Toxicol. 2015;82:64–71.
   PubMed Web of Science ®Google Scholar
• Xue L, Murray JH, Tolkovsky AM. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J Biol Chem. 2000;275(12):8817–8824.
   PubMed Web of Science ®Google Scholar
• Kipp M, Clarner T, Gingele S, Pott F, Amor S, Van Der Valk P, et al. Brain lipid binding protein (FABP7) as modulator of astrocyte function. Physiol Res. 2011;60:85–98.
   Web of Science ®Google Scholar
• Hegazy HG, Ali EHA, Sabry HA. The neuroprotective action of naringenin on oseltamivir (tamiflu) treated male rats. J Basic Appl Zool. 2016;77:83–90.
   Google Scholar
• Lee M-K, Moon S-S, Lee S-E, Bok S-H, Jeong T-S, Park YB, Choi M-S. Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats. Bioorg Med Chem. 2003;11(3):393–398.
   PubMed Web of Science ®Google Scholar
• Lee C-H, Jeong T-S, Choi Y-K, Hyun B-H, Oh G-T, Kim E-H, et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun. 2001;284(3):681–688.
   PubMed Web of Science ®Google Scholar
• Liu L, Shan S, Zhang K, Ning Z, Lu X, Cheng Y. Naringenin and hesperetin, two flavonoids derived from citrus aurantium up-regulate transcription of adiponectin. Phytotherapy Res: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2008;22(10):1400–1403.
   Google Scholar
• Li P, Wang S, Guan X, Liu B, Wang Y, Xu K, et al. Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats. Food Chem Toxicol. 2013;60:1–9.
   PubMed Web of Science ®Google Scholar
• Burke AC, Sutherland BG, Telford DE, Morrow MR, Sawyez CG, Edwards JY, et al. Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice. J Lipid Res. 2018;59(9):1714–1728.
   PubMed Web of Science ®Google Scholar
• Toth C, Lander J, Wiebe S. The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med. 2009;10(5):918–929.
   PubMed Web of Science ®Google Scholar
• Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10(1):23–36.
   PubMed Web of Science ®Google Scholar
• Somers DL, Clemente FR. Transcutaneous electrical nerve stimulation for the management of neuropathic pain: the effects of frequency and electrode position on prevention of allodynia in a rat model of complex regional pain syndrome type II. Phys Therapy. 2006;86(5):698–709.
   PubMed Web of Science ®Google Scholar
• Léonard G, Cloutier C, Marchand S. Reduced analgesic effect of acupuncture-like TENS but not conventional TENS in opioid-treated patients. J Pain. 2011;12(2):213–221.
   PubMed Web of Science ®Google Scholar
• Qiao L, Guo M, Qian J, Xu B, Gu C, Yang Y. Research advances on acupuncture analgesia. Am J Chin Med. 2020;48(02):245–258.
   PubMedGoogle Scholar
• Ge M-M, Li D-Y, Wang L, Zhang L-Q, Liu D-Q, Tian Y-K, et al. Naringenin promoted spinal microglia M2 polarization in rat model of cancer-induced bone pain via regulating AMPK/PGC-1α signaling axis. Biomed Pharmacotherapy. 2022;149:68–72.
   Web of Science ®Google Scholar
• Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y.. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARα, PPARγ and LXRα. PLoS One. 2010;5(8):773–784.
   Web of Science ®Google Scholar
• Kaulaskar S, Bhutada P, Rahigude A, Jain D, Harle U. Effects of naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain. Zhong Xi Yi Jie He Xue Bao. 2012;10(12):1482–1489.
   PubMedGoogle Scholar
• Al-Rejaie SS, Aleisa AM, Abuohashish HM, Parmar MY, Ola MS, Al-Hosaini AA, Ahmed MM. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurol Res. 2015;37(10):924–933.
   PubMed Web of Science ®Google Scholar
• Chin RFM, Neville BGR, Scott RC. Meningitis is a common cause of convulsive status epilepticus with fever. Arch Dis Childhood. 2005;90(1):66–69.
   PubMed Web of Science ®Google Scholar
• Shorvon SD. The causes of epilepsy: changing concepts of etiology of epilepsy over the past 150 years. Epilepsia. 2011;52(6):1033–1044.
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Human neurocysticercosis: an overview. Pathogens. 2022;11(10):1212–1218.
   PubMed Web of Science ®Google Scholar
• Shakeel S, Rehman MU, Tabassum N, Amin U. Effect of naringenin (a naturally occurring flavanone) against pilocarpine-induced status epilepticus and oxidative stress in mice. Pharmacogn Mag. 2017;13(Suppl 1):154–162.
   Google Scholar
• Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, et al. A prospective community-based study of stroke in Germany—the erlangen stroke project (ESPRO) incidence and case fatality at 1, 3, and 12 months. Stroke. 1998;29(12):2501–2506.
   PubMed Web of Science ®Google Scholar
• Khodayar MJ, Salehi S, Rezaei M, Siahpoosh A, Khazaei A, Houshmand G. Evaluation of the effect of naringenin on pentylenetetrazole and maximal electroshock-induced convulsions in mice. Jundishapur J Nat Pharm Prod. 2017;12:23–29.
   Google Scholar
• Park J, Jeong KH, Shin W-H, Bae Y-S, Jung UJ, Kim SR. Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy. Neuroreport. 2016;27(15):1182–1189.
   PubMed Web of Science ®Google Scholar
• Feifel D, Shilling PD, MacDonald K. A review of oxytocin's effects on the positive, negative, and cognitive domains of schizophrenia. Biol Psychiatry. 2016;79(3):222–233.
   PubMed Web of Science ®Google Scholar
• Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31(5):234–242.
   PubMed Web of Science ®Google Scholar
• Obrosova IG. Diabetes and the peripheral nerve. Biochim Biophys Acta (BBA)-Molecular Basis of Disease. 2009;1792(10):931–940.
   PubMed Web of Science ®Google Scholar
• Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol. 2015;29(2):97–115.
   PubMed Web of Science ®Google Scholar
• Li P-F, Dietz R, von Harsdorf R. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 1999;18(21):6027–6036.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, et al. IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 2005;67(4):1216–1233.
   PubMed Web of Science ®Google Scholar
• Higley MJ, Picciotto MR. Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol. 2014;29:88–95.
   PubMed Web of Science ®Google Scholar
• Zou W, Xiao Z, Wen X, Luo J, Chen S, Cheng Z, et al. The anti-inflammatory effect of andrographis paniculata (burm. f.) nees on pelvic inflammatory disease in rats through down-regulation of the NF-κB pathway. BMC Complement Altern Med. 2016;16:1–7.
   PubMed Web of Science ®Google Scholar
• Shorter E.How everyone became depressed: The rise and fall of the nervous breakdown. Oxford (England): Oxford University Press; 2013.
   Google Scholar
• Patel K, Singh GK, Patel DK. A review on pharmacological and analytical aspects of naringenin. Chin J Integr Med. 2018;24:551–560.
   PubMed Web of Science ®Google Scholar
• Mitra S, Lami MS, Uddin TM, Das R, Islam F, Anjum J, et al. Prospective multifunctional roles and pharmacological potential of dietary flavonoid narirutin. Biomed Pharmacother. 2022b;150:345–351.
   Web of Science ®Google Scholar
• Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs. 2001;15:797–817.
   PubMed Web of Science ®Google Scholar
• Mitra S, Anjum J, Muni M, Das R, Rauf A, Islam F, et al. Exploring the journey of emodin as a potential neuroprotective agent: novel therapeutic insights with molecular mechanism of action. Biomed Pharmacother. 2022a;149:456–463.
   Web of Science ®Google Scholar
• Yi L-T, Li C-F, Zhan X, Cui C-C, Xiao F, Zhou L-P, Xie Y. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1223–1228.
   PubMed Web of Science ®Google Scholar
• Yi L-T, Liu B-B, Li J, Luo L, Liu Q, Geng D, et al. BDNF signaling is necessary for the antidepressant-like effect of naringenin. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:135–141.
   PubMed Web of Science ®Google Scholar
• Pathak L, Agrawal Y, Dhir A. Natural polyphenols in the management of major depression. Expert Opin Investig Drugs. 2013;22(7):863–880.
   PubMed Web of Science ®Google Scholar
• Stafford GI, Pedersen ME, van Staden J, Jäger AK. Review on plants with CNS-effects used in traditional South African medicine against mental diseases. J Ethnopharmacol. 2008;119(3):513–537.
   PubMed Web of Science ®Google Scholar
• Salman M, Sharma P, Alam MI, Tabassum H, Parvez S. Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington's disease like symptoms in rats. Nutr Neurosci. 2022b;25(9):1898–1908.
   PubMed Web of Science ®Google Scholar
• El Madani MA, Elsalam RMA, Attia AS, El-Shenawy SM, Arbid MS. Neuropharmacological effects of naringenin, harmine and adenosine on parkinsonism induced in rats. Scholars Res Library. 2016;8(5):45–57.
   Google Scholar
• Chen C, Wei Y-Z, He X-M, Li D-D, Wang G-Q, Li J-J, et al. Naringenin produces neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation. Front Immunol. 2019;10:21–29.
   PubMed Web of Science ®Google Scholar
• Kabir MSH, Hossain MM, Kabir MI, Rahman MM, Hasanat A, Emran T Bin, et al. Phytochemical screening, antioxidant, thrombolytic, alpha-amylase inhibition and cytotoxic activities of ethanol extract of steudnera colocasiifolia K. koch leaves. J Young Pharmacists. 2016;8(4):24–29.
   Google Scholar
• Mani S, Sekar S, Chidambaram SB, Sevanan M. Naringenin protects against 1-methyl-4-phenylpyridinium-induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line: an: in vitro: model of Parkinson's disease. Pharmacogn Mag. 2018b;14(57):458–464.
   Web of Science ®Google Scholar
• Mercer LD, Kelly BL, Horne MK, Beart PM. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem Pharmacol. 2005;69(2):339–345.
   PubMed Web of Science ®Google Scholar
• Kesh S, Kannan RR, Balakrishnan A. Naringenin alleviates 6-hydroxydopamine induced parkinsonism in SHSY5Y cells and zebrafish model. Comp Biochem Physiol C Toxicol Pharmacol. 2021;239:101–121.
   Web of Science ®Google Scholar
• Zhang B, Wei YZ, Wang GQ, Li DD, Shi JS, Zhang F. Targeting MAPK pathways by naringenin modulates microglia M1/M2 polarization in lipopolysaccharide-stimulated cultures. Front Cell Neurosci. 2019;12:531–543.
   PubMed Web of Science ®Google Scholar
• Hu CY, Zhao Y. Analgesic effects of naringenin in rats with spinal nerve ligation–induced neuropathic pain. Biomed Rep. 2014;2(4):569–573.
   PubMedGoogle Scholar
• Tayyab M, Farheen S, Khanam N, Mobarak Hossain M, Shahi MH. Antidepressant and neuroprotective effects of naringenin via sonic hedgehog-GLI1 cell signaling pathway in a rat model of chronic unpredictable mild stress. Neuromolecular Med. 2019;21:250–261.
   PubMed Web of Science ®Google Scholar
• Yi L-T, Li J, Li H-C, Su D-X, Quan X-B, He X-C, Wang X-H. Antidepressant-like behavioral, neurochemical and neuroendocrine effects of naringenin in the mouse repeated tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):175–181.
   PubMed Web of Science ®Google Scholar
• Olugbemide AS, Ben-Azu B, Bakre AG, Ajayi AM, Femi-Akinlosotu O, Umukoro S. Naringenin improves depressive-and anxiety-like behaviors in mice exposed to repeated hypoxic stress through modulation of oxido-inflammatory mediators and NF-kB/BDNF expressions. Brain Res Bull. 2021;169:214–227.
   PubMed Web of Science ®Google Scholar